NRXP NRX Pharmaceuticals, Inc. - Common Stock
NASDAQ · Pharmaceuticals · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 14, 2026NRXP Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
NRXP Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
| Ex-date | Split | Type |
|---|---|---|
| April 2, 2024 | 1-for-10 | Reverse |
10-Year Performance Revenue, net income, margins and EPS trends
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | NRXP | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/B (MRQ) | -737.5 | · | · | · | |
| Price / Tangible Book (MRQ) | -125.1 | · | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Not enough fundamentals data to compute this ratio group yet.
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | NRXP | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio (MRQ) | 0.9 | · | 5.0 | Low liquidity |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Not enough fundamentals data to compute this ratio group yet.
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Aug 14, 2026 | $-0.44 | $0.07 | -773.8% |
| March 31, 2026 | May 15, 2026 | $-0.04 | $0.29 | -113.6% |
| Dec. 31, 2025 | $-0.01 | $-0.00 | — | |
| Sept. 30, 2025 | $-0.50 | $-0.09 | -476.7% | |
| June 30, 2025 | $-0.31 | $-0.21 | -49.5% | |
| March 31, 2025 | $-0.21 | $-0.31 | 31.4% | |
| Dec. 31, 2024 | $-0.77 | $-0.32 | -138.4% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Balance Sheet
| Metric | Trend | 2025 |
|---|---|---|
| Cash & Equivalents | $8M | |
| Receivables | $161.0K | |
| Prepaid Expense | $934.0K | |
| Current Assets | $9M | |
| PP&E (Net) | $63.0K | |
| PP&E (Gross) | $93.0K | |
| Accum. Depreciation | $30.0K | |
| Goodwill | $2M | |
| Intangibles | $925.0K | |
| Other Non-current Assets | $253.0K | |
| Total Assets | $13M | |
| Accounts Payable | $4M | |
| Current Liabilities | $29M | |
| Total Liabilities | $29M | |
| Common Stock | $32.0K | |
| Paid-in Capital | $291M | |
| Retained Earnings | $-307M | |
| Stockholders' Equity | $-16M | |
| Liabilities + Equity | $13M | |
| Shares Outstanding | 31,734,333 |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q1 2025 |
|---|---|---|---|---|
| Revenue | $1M | $1M | $0 | |
| Cost of Revenue | $675.0K | $631.0K | $0 | |
| R&D Expense | $2M | $1M | $804.0K | |
| SG&A Expense | $5M | $4M | $3M | |
| Operating Expenses | $8M | $6M | $4M | |
| Operating Income | $-7M | $-5M | $-4M | |
| Interest Income | $6.0K | $5.0K | $4.0K | |
| Other Non-op | $-10M | $3M | $-2M | |
| Income Tax | $0 | $0 | $0 | |
| Net Income | $-17M | $-1M | $-6M | |
| EPS (Basic) | $-0.44 | $-0.04 | $-0.34 | |
| Shares (Basic) | 37,649,382 | 32,325,323 | 16,410,062 | |
| EBITDA | $-7M | $-5M | · |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q1 2025 |
|---|---|---|---|---|
| Cash & Equivalents | $27M | $7M | · | |
| Receivables | $206.0K | $181.0K | · | |
| Prepaid Expense | $2M | $467.0K | · | |
| Current Assets | $29M | $7M | · | |
| PP&E (Net) | $919.0K | $259.0K | · | |
| PP&E (Gross) | $990.0K | $306.0K | · | |
| Accum. Depreciation | $71.0K | $47.0K | · | |
| Goodwill | $2M | $2M | · | |
| Intangibles | $832.0K | $879.0K | · | |
| Other Non-current Assets | $224.0K | $276.0K | · | |
| Total Assets | $34M | $12M | · | |
| Accounts Payable | $3M | $4M | · | |
| Current Liabilities | $34M | $25M | · | |
| Total Liabilities | $34M | $26M | · | |
| Common Stock | $43.0K | $33.0K | · | |
| Paid-in Capital | $325M | $294M | · | |
| Retained Earnings | $-325M | $-308M | · | |
| Stockholders' Equity | $-170.0K | $-14M | · | |
| Liabilities + Equity | $34M | $12M | · | |
| Shares Outstanding | 43,157,744 | 33,471,315 | · |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q1 2025 |
|---|---|---|---|---|
| D&A | $71.0K | $63.0K | $1.0K | |
| Stock-based Comp | $139.0K | $151.0K | $12.0K | |
| Other Non-cash | · | $-3M | · | |
| Operating Cash Flow | $-9M | $-4M | $-3M | |
| Investing Cash Flow | $-684.0K | $-213.0K | $0 | |
| Stock Issued | · | $3M | $0 | |
| Net Stock Activity | · | $3M | · | |
| Financing Cash Flow | $30M | $3M | $8M | |
| Net Change in Cash | $20M | $-1M | $4M | |
| Taxes Paid | $0 | $0 | $0 |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q1 2025 |
|---|---|---|---|---|
| Operating Margin | -590.8% | -444.0% | · | |
| Net Margin | -1500.5% | -133.9% | · | |
| EBITDA Margin | -590.8% | -438.1% | · | |
| ROA | -84.7% | -14.7% | · | |
| ROE | 92.3% | 7.3% | · |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q1 2025 |
|---|---|---|---|---|
| Current Ratio | 0.9 | 0.3 | · | |
| Quick Ratio | 0.8 | 0.3 | · |
Efficiency
| Metric | Trend | Q2 2026 | Q1 2026 | Q1 2025 |
|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | |
| Receivables Turnover | 10.7 | 11.8 | · |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q1 2025 |
|---|---|---|---|---|
| Book Value / Share | $-0.00 | $-0.41 | · | |
| Cash / Share | $0.62 | $0.20 | · |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q1 2025 |
|---|---|---|---|---|
| Revenue TTM | $3M | $2M | · | |
| Net Income TTM | $-23M | $-25M | · | |
| Market Cap | $177M | $71M | · | |
| P/S | 52.0 | 31.1 | · | |
| P/B | -1038.3 | -5.2 | · | |
| P / Cash Flow | · | -16.6 | · |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
Not enough fundamentals data to build this statement yet.
Not enough fundamentals data to build this statement yet.
Not enough fundamentals data to build this statement yet.
Institutional owners (13F) 53 filers · $51.3M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 19 (+5 vs prior Q) | 5 (+1 vs prior Q) | 20 (+5 vs prior Q) | 6 (+4 vs prior Q) | +5.7M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| B Group, Inc. | $16,735,327 | 4,091,767 | 32.60% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $6,618,270 | 1,618,159 | 12.89% | Shares |
| AMERIPRISE FINANCIAL INC | $3,798,498 | 928,728 | 7.40% | Shares |
| Balyasny Asset Management L.P. | $3,655,904 | 893,864 | 7.12% | Shares |
| CITADEL ADVISORS LLC | $2,781,376 | 680,043 | 5.42% | Shares |
| AdvisorShares Investments LLC | $2,695,384 | 659,018 | 5.25% | Shares |
| VANGUARD GROUP INC | $1,977,871 | 729,842 | 3.85% | Shares |
| COMMONWEALTH EQUITY SERVICES, LLC | $1,858,570 | 454,418 | 3.62% | Shares |
| UBS Group AG | $1,730,540 | 423,115 | 3.37% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $1,287,102 | 314,659 | 2.51% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $927,612 | 226,800 | 1.81% | Call option |
| CITADEL ADVISORS LLC | $916,978 | 224,200 | 1.79% | Call option |
| BlackRock, Inc. | $901,681 | 220,460 | 1.76% | Shares |
| MARSHALL WACE, LLP | $795,831 | 194,580 | 1.55% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $747,317 | 182,718 | 1.46% | Shares |
| JANE STREET GROUP, LLC | $486,784 | 119,018 | 0.95% | Shares |
| Bleakley Financial Group, LLC | $479,413 | 117,216 | 0.93% | Shares |
| STATE STREET CORP | $474,784 | 116,084 | 0.92% | Shares |
| NORTHERN TRUST CORP | $257,470 | 62,951 | 0.50% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $215,543 | 52,700 | 0.42% | Put option |
| Chicago Partners Investment Group LLC | $190,655 | 46,388 | 0.37% | Shares |
| Quadrature Capital Ltd | $178,344 | 43,605 | 0.35% | Shares |
| One Wealth Management Investment & Advisory Services, LLC | $177,134 | 43,309 | 0.35% | Shares |
| MORGAN STANLEY | $167,285 | 40,901 | 0.33% | Shares |
| RENAISSANCE TECHNOLOGIES LLC | $157,874 | 38,600 | 0.31% | Shares |
| Global Retirement Partners, LLC | $136,197 | 33,300 | 0.27% | Shares |
| CITADEL ADVISORS LLC | $109,203 | 26,700 | 0.21% | Put option |
| TWO SIGMA INVESTMENTS, LP | $108,095 | 26,429 | 0.21% | Shares |
| TRUIST FINANCIAL CORP | $81,800 | 20,000 | 0.16% | Shares |
| ExodusPoint Capital Management, LP | $78,970 | 19,308 | 0.15% | Shares |
| JANE STREET GROUP, LLC | $76,074 | 18,600 | 0.15% | Call option |
| XTX Topco Ltd | $75,849 | 18,545 | 0.15% | Shares |
| Persistent Asset Partners Ltd | $66,773 | 16,326 | 0.13% | Shares |
| Cresset Asset Management, LLC | $61,350 | 15,000 | 0.12% | Shares |
| SJBENEN ADVISORY, LLC | $57,750 | 15,000 | 0.11% | Shares |
| Squarepoint Ops LLC | $53,849 | 13,166 | 0.10% | Shares |
| Ethos Financial Group, LLC | $51,357 | 15,900 | 0.10% | Shares |
| MILLENNIUM MANAGEMENT LLC | $50,327 | 12,305 | 0.10% | Shares |
| CITIGROUP INC | $24,507 | 5,992 | 0.05% | Shares |
| Vanguard Global Advisers, LLC | $23,612 | 5,773 | 0.05% | Shares |
| SBI Securities Co., Ltd. | $20,863 | 5,101 | 0.04% | Shares |
| Tower Research Capital LLC (TRC) | $15,886 | 3,884 | 0.03% | Shares |
| WELLS FARGO & COMPANY/MN | $8,180 | 2,000 | 0.02% | Shares |
| ROYAL BANK OF CANADA | $8,000 | 2,000 | 0.02% | Shares |
| BARCLAYS PLC | $3,681 | 900 | 0.01% | Shares |
| OSAIC HOLDINGS, INC. | $2,454 | 600 | 0.00% | Shares |
| HRT FINANCIAL LP | $411 | 100,724 | 0.00% | Shares |
| Caitong International Asset Management Co., Ltd | $274 | 67 | 0.00% | Shares |
| JPMORGAN CHASE & CO | $136 | 34 | 0.00% | Shares |
| Larson Financial Group LLC | $90 | 22 | 0.00% | Shares |
Activists & 5%+ owners 4 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Daniel C. Javitt | Sept. 13, 2022 | · | Initial filing | Passive investment | SEC |
| Jonathan C. Javitt ×4 filings | June 17, 2022 | · | Initial filing | · | SEC |
| David M. Nussbaum, Steven Levine, BRAC Lending Group LLC ×2 filings | June 4, 2021 | · | Initial filing | Passive investment | SEC |
| Big Rock Partners Sponsor, LLC, Richard Ackerman ×3 filings | May 26, 2021 | · | Initial filing | Passive investment | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 18 insiders · 7 officers · 9 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Stephen H Willard | CHIEF EXECUTIVE OFFICER | Dec. 16, 2022 P | 50,000 | 0 | 0 | $0 |
| Robert Besthof | Interim CEO | March 8, 2022 A | 23,710 | 0 | 0 | $0 |
| Michael S Abrams | Chief Financial Officer | Feb. 7, 2025 A | · | 0 | 0 | $0 |
| Seth Van Voorhees | CHIEF FINANCIAL OFFICER | Dec. 16, 2022 P | 46,337 | 0 | 0 | $0 |
| Joseph Michael Casper | Chief Operating Officer | Jan. 27, 2026 A | · | 0 | 0 | $0 |
| Jonathan C Javitt | Chairman and Chief Scientist | April 9, 2025 A | 84,634 | 0 | 0 | $0 |
| Alessandra Daigneault | General Counsel & Secretary | Sept. 2, 2021 A | 31,584 | 0 | 0 | $0 |
| Dennis Mcbride | Director | April 9, 2025 A | · | 0 | 0 | $0 |
| Patrick John Flynn | Director | April 9, 2025 A | 1,750 | 0 | 0 | $0 |
| Chaim Hurvitz | Director | April 9, 2025 A | 570,000 | 0 | 0 | $0 |
| Aaron Gorovitz | Director | Aug. 30, 2023 P | 105,000 | 0 | 0 | $0 |
| Sharon Glied | Director | Oct. 21, 2022 A | 13,168 | 0 | 0 | $0 |
| Herbert Raymond Mcmaster | Director | Aug. 26, 2021 A | 18,300 | 0 | 0 | $0 |
| Daniel Troy | Director | May 24, 2021 A | 43,093 | 0 | 0 | $0 |
| Daniel C. Javitt | 10% owner | Nov. 30, 2022 S | 9,634,793 | 0 | 0 | $0 |
| Polar Securities Inc. | 10% owner | March 13, 2020 S | 488,036 | 0 | 0 | $0 |
| BRAC Lending Group LLC | · | May 24, 2021 D | 590,435 | 0 | 0 | $0 |
| William Fricker | · | May 24, 2021 A | · | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 3 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
NRXP Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
12-Month Price Target
4 analysts · 2026-10-04Mean target $38.50 +1225.3%
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
| Ticker | Market Cap | P/E | Rev YoY | Net Margin | ROE | Gross Margin |
|---|---|---|---|---|---|---|
| NRXP | · | · | · | · | · | · |
| ORMP | $112M | 1.9 | -50.4% | 3202.5% | 37.0% | 0.65% |
| RANI | · | -3.0 | 58.9% | -1817.1% | -169.6% | · |
| LENZ | $502M | -5.6 | · | -430.2% | -33.5% | · |
| AARD | $286M | -4.5 | · | · | -47.3% | · |
| CPIX | $60M | -20.9 | 17.6% | -6.4% | -11.9% | · |
| PLYX | · | · | · | · | -193.7% | · |
| LLY | · | 46.8 | 44.7% | 31.7% | 101.2% | · |
Latest News Recent headlines mentioning this company
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.